Complex visual hallucinations may affect some normal individuals on going to sleep and are also seen in pathological states, often in association with a sleep disturbance. The content of these hallucinations is striking and relatively stereotyped, often involving animals and human figures in bright colours and dramatic settings. Conditions causing these hallucinations include narcolepsy-cataplexy syndrome, peduncular hallucinosis, treated idiopathic Parkinson's disease, Lewy body dementia without treatment, migraine coma, Charles Bonnet syndrome (visual hallucinations of the blind), schizophrenia, hallucinogeninduced states and epilepsy. We describe cases of hallucinosis due to several of these causes and expand on previous hypotheses to suggest three mechanisms underlying complex visual hallucinations. (i) Epileptic Keywords: visual hallucinations; thalamocortical; arousal; serotonin Abbreviations: 5HT ϭ 5-hydroxytryptamine; LSD ϭ lysergic acid diethylamine tartrate; PGO ϭ ponto-geniculo-occipital (waves); REM ϭ rapid eye movement
Introduction
coined the term hypnagogic hallucinations to describe his own vivid hallucinations in the state of drowsiness, just before sleep. There have been several further detailed descriptions of the phenomenon, especially that by Leaning (Baillarger, 1846; Leroy, 1922; Leaning, 1926; Tournay, 1941; Foulkes and Vogel, 1965) . Up to one-third of normal individuals may experience these hallucinations, when going off to sleep, anywhere from once in a lifetime to most nights, but they are particularly common in the narcolepsy-cataplexy syndrome. The hallucinations may last from a few seconds to ജ15 min, probably depending on the duration of this stage of drowsiness. Fever may trigger the hallucinations in those predisposed and even in these early series, it was recognized that sufferers often had poor vision
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hallucinations are probably due to a direct irritative process acting on cortical centres integrating complex visual information. (ii) Visual pathway lesions cause defective visual input and may result in hallucinations from defective visual processing or an abnormal cortical release phenomenon. (iii) Brainstem lesions appear to affect ascending cholinergic and serotonergic pathways, and may also be implicated in Parkinson's disease. These brainstem abnormalities are often associated with disturbances of sleep. We discuss how these lesions, outside the primary visual system, may cause defective modulation of thalamocortical relationships leading to a release phenomenon. We suggest that perturbation of a distributed matrix may explain the production of similar, complex mental phenomena by relatively blunt insults at disparate sites. (Leaning, 1926) . The content of the hallucinations is dramatic; they are usually in vivid colours and may evolve from simple spots of light through geometric patterns to complex images, or they may be complex from the outset. Sufferers often see human figures or faces (sometimes torsos without heads or vice versa); animals (real or bizarre), sometimes in miniature (Lilliputian hallucinations) or scenery of outstanding beauty. The images may be static or moving and their detail and vividness seem to exceed anything experienced in real life. In contrast to the dreams of deep sleep, the dreamer is on the outside observing the action which may evolve slightly but there is rarely a 'plot' in which the dreamer is actively involved. Modalities other than vision may be involved, especially faces may talk, but this is relatively uncommon.
The emotional reaction to the images may be neutral, pleasant fascination or extreme fear.
Several pathological conditions may be associated with very similar, striking hallucinations (often with preserved insight) and altered awareness (Table 1) . They include peduncular hallucinosis, delirium tremens, drug-induced hallucinations, migraine coma, treated Parkinson's disease, Lewy body dementia and Charles Bonnet syndrome (hallucinations of the blind). The patient's belief in the reality of the images varies between conditions, and is especially affected by cognitive factors and their level of awareness. The patients least likely to be distressed by the hallucinations are those with Charles Bonnet syndrome, perhaps reflecting preservation of CNS function and adaptability. In general, once familiar with the hallucinations, the patients find them non-threatening and have insight into their nature, in distinction to hallucinations associated with psychiatric illness.
It has been difficult to find a common thread to explain the occurrence of hallucinations in these diverse conditions, but their striking similarity suggests that they may act through related mechanisms, despite apparently disparate lesion sites and disease processes. The pathology is sometimes extracortical, for example in peduncular hallucinosis and Charles Bonnet syndrome. In other conditions, for instance delirium tremens and drug-induced hallucinations, there is no fixed pathological substrate. Although the extracortical visual system may support some visual function, this is vague and semiconscious (Cowey and Stoerig, 1991; Matthews and Kennard, 1993) . It seems likely, therefore, that the visual detail of these sorts of hallucinations is due to a cortical phenomenon, although some of the causes may be acting on the cortex indirectly or from a remote site. Previous authors have suggested three basic underlying mechanisms: (i) irritative processes in the association cortex generating discharges falsely interpreted as due to sensory inputs; (ii) release phenomena due to defective visual input causing faulty cortical stimulation; and (iii) faulty visual processing in which inputs are normal but lesions result in an inappropriate pattern of cortical excitation (Cogan, 1973; Asaad and Shapiro, 1986) . These general statements have never been taken further to try and provide a more detailed neurobiological explanation for hallucinations.
We describe the similarities and differences in clinical features of the various causes of complex hallucinations in relation to their pathophysiology to try and elucidate possible common elements. We shall explore how these conditions could influence activity in striate, extrastriate and association cortices and in subcortical visual centres.
Clinical features of complex hallucinations in diverse conditions

Peduncular hallucinosis Case 1
Whilst watching television, this 58-year-old man developed a vertical split of the visual image. One-half appeared higher than the other and the symptom resolved after 1 min. Ten days later he developed a ball of light, with a red and blue surround in his left visual hemifield, associated with headache and mild drowsiness. This lasted 2-3 min but recurred many times over several hours. The images then changed to a man in a suit and a black butterfly, occurring especially with his eyes shut. The symptoms improved over several days but hallucinations and distressing dreams recurred several weeks later. Hallucinations always occurred when he was relaxed but awake, with his eyes shut and waiting to go to sleep. He lay and watched them for prolonged periods until he fell asleep. They were not restricted to one part of the visual field and disappeared on opening his eyes. They never occurred at times of poor illumination if his eyes were open. He often saw a dwarf whose face was hidden by a lamp. The dwarf was accompanied by a clown in a striped grey suit. On one occasion there were three dwarves with eggshaped heads who were at the bottom of his bed. They were wearing cloaks and playing with his feet, although he did not feel anything abnormal in his feet. One dwarf had a 'comforting golden face with blue eyes' and told him: 'It's all over'. He has also seen figures dressed in 17th century Cavalier's clothes or women in Victorian clothes pushing wicker perambulators with babies. When asleep he had vivid dreams including bright, striped fish swimming across his view. In retrospect, he understood these hallucinations were not real but, at the time, he was frightened by them.
Non-insulin-dependent diabetes mellitus and mild hypertension were diagnosed at his first presentation, but there was no other significant medical history. MRI scan showed small specks of increased T 2 signal, consistent with ischaemia in the right basal ganglia and right thalamus, including the pulvinar. [ 18 F]Fluorodeoxyglucose-PET showed a larger area of ischaemia in the right thalamus and ipsilateral occipital cortex (Fig. 1) .
Visual fields and visual evoked potentials were normal. Neuropsychometric assessment was entirely normal with no visuospatial deficit. Brainstem evoked potentials showed loss of waves II-IV but a normal I-V interval. No episodes of hallucinosis occurred during 48 h of ambulatory EEG. The EEG was normal and sleep architecture appeared normal.
Comment. In his case, the investigations and clinical picture point to an abnormality at thalamic or cortical level although there is no current clinical or investigation evidence of visual pathway malfunction or cortical disease. The reduced blood flow in occipital cortex may represent primary cortical involvement or reduced activity, secondary to under-activity of the afferent thalamic nuclei.
Case 2
A 50-year-old woman had a history of rheumatic heart disease, requiring valve surgery at the age of 25 years. At the age of 46 years, she developed a sudden onset of mild right hemiparesis with dysphasia, which recovered spontaneously. A few months later she had her first episode of hallucinosis, which then recurred roughly monthly. A typical episode started with an aura of nausea, vomiting and occasionally vertigo. This would last up to 5 min and she tried to lie down. On three occasions, when she had not been able to make herself safe, she sustained falls with fractures. She described four tall men-so tall she could not see their heads-in pinstripe suits. Two were on either side of her. Their hands were pink, though they appeared to be made only of bones. In front of her was a large pit filled with coloured, shiny snakes, including dancing cobras. The men tried to throw her into the pit and the snakes tried to coil around her legs. On one occasion the men managed to get her into the pit and it immediately turned into a tunnel with a golden gate at the end. During the hallucination, which lasted 30-150 min, she was unable to see anything around her. Two episodes were observed in hospital. They started with a complaint of headache. Then she would stare, retch and vomit. There were tremors of both arms and she started to talk about monsters. She was in a dream-like state, with diminished responsiveness, but she was not unconscious. Her husband described her trying to grab his neck, especially if he tried to put her to bed and she would shout: 'I don't want to go!'. After the episode she felt sick with a severe leftsided headache; the nausea was severe, and she tried to go to sleep. On one occasion, when she awoke, she told her husband: 'There they are again!'.
She had a persistent, milder headache between episodes. There was also a history of sudden-onset bilateral, transient blindness. Treatment with anti-epileptic drugs was of no benefit. Examination showed a mild right hemiparesis but visual fields were full. CT scan showed a markedly dilated left lateral ventricle with the septum pellucidum deviating to the right but no other abnormality. A metrizamide ventriculogram showed a diverticulum, which protruded through the incisura into the posterior fossa, compressing the brainstem from above. Visual evoked responses were normal. An EEG conducted during one of the episodes, showed mainly artefact. Monitoring of the pressure of the left lateral ventricle yielded low values, mostly 0-1 cm of water with a single rise to 8 cm. Ventriculoscopy showed no evidence of a lesion, and a diagnosis of loculated ventricle was made. A small hole was made in the septum pellucidum. This was followed by resolution of her preoperative hallucinations, but she developed a severe amnesic state with confabulation, indistinguishable from Korsakoff's syndrome. These changes were long-lasting but there was eventually some improvement in her memory. CT scan did not show reduction in the shift identified preoperatively. Stereotyped hallucinations involving her mother also developed postoperatively, but were less well described.
Comment. The aetiology of this woman's complex visual hallucinations probably related to midbrain distortion due to ventricular loculation. They were episodic and associated with headache, and migraine may also have been involved. Her postoperative Korsakoff's syndrome was probably due to disconnection and interference with the function of the mamillary region. Peduncular hallucinosis was originally described by Lhermitte in association with a rostral brainstem lesion (Lhermitte, 1922) . It is characterized by striking visual images very similar to hypnagogic hallucinations (for cases and references, see the Appendix). Hallucinations generally start a few days after infarction and subside a few weeks later, but they may persist for years. The hallucinations usually last minutes to several hours, but in some cases, they may persist throughout waking. The most common diurnal pattern is for hallucinations to disappear through the day then recur each evening. They are occasionally accompanied by tactile and auditory hallucinations. There is often an associated disturbance of consciousness, and abnormally vivid dreams may occur, with peculiar states of inaccessibility. Patients usually have insight into the hallucinations, and once they understand the phenomenon, they cope with it well, without features of paranoia or psychiatric disturbance (Baska, 1992) .
Lesions causing peduncular hallucinosis
The aetiology is most commonly vascular and the site of the lesion is generally in the rostral brainstem. These cases seem Fig. 2 Representative horizontal sections through the brainstem at the level of (A) the posterior commissure, (B) the oculomotor nucleus and (C) the abducens nucleus, showing sites of lesions causing peduncular hallucinosis documented by neuroimaging or pathology. The greater the density of dots, the more reports of lesions affecting that area. a ϭ aqueduct; an ϭ abducens nucleus; cp ϭ cerebral peduncle; ctt ϭ central tegmental tract; fn ϭ facial nucleus; IV ϭ fourth ventricle; ml ϭ medial lemniscus; mlf ϭ medial longitudinal fasciculus; mcp ϭ middle cerebellar peduncle; on ϭ oculomotor nucleus; pag ϭ periaqueductal grey matter (includes raphe nuclei); pc ϭ posterior commissure; rf ϭ reticular formation; rn ϭ red nucleus; sc ϭ superior colliculus; son ϭ superior olivary nucleus; sn ϭ substantia nigra; snt ϭ spinal nucleus and tract of trigeminal nerve. Lesions appear to be concentrated in the paramedian reticular formation from pontine to midbrain levels, with the maximum density of lesions in the midbrain, close to the level of the oculomotor and raphe nuclei.
to have in common an effect on the brainstem reticular formation or its targets in the thalamus (Appendix and Fig.  2 ). These locations are all the more surprising in that the lesions do not directly involve the retinogeniculocortical system, which is generally considered to be required for the appreciation of complex form and colour.
Lesions restricted to the thalamus have been described. They have included the pulvinar and medial thalamus, but medial thalamic lesions usually also include rostral brainstem structures (Castaigne et al., 1981; Bassetti et al., 1996) . Additional cases have lesions which appear to be restricted to the region of the cerebral peduncle, but in this situation they are also likely to affect the nucleus reticularis thalami and the substantia nigra. One case, examined pathologically, revealed lesions restricted to the substantia nigra pars reticulata. The nigra pars reticulata receives inputs from both serotonergic raphe neurons and cholinergic cells of the pedunculopontine tegmental nucleus (Jackson and Crossman, 1983; Beninato and Spencer, 1987) and sends reciprocal efferents to the pedunculo-pontine tegmental nucleus and reticular formation as well as to the parafascicular nucleus of the thalamus. The nigra pars reticulata is thus closely connected to nuclei more commonly implicated in peduncular hallucinosis (Beckstead et al., 1979; Beckstead, 1983) .
Hallucinations in Parkinson's disease Case 3
A 68-year-old man had an 11-year history of Parkinson's disease. This initially manifested as tremor and stiffness of his right arm. He was treated with levodopa, with a good response for 7 years. Subsequently it became more difficult to control his symptoms, which had become bilateral. Adjusting his medication, with increased dose of levodopa or dopaminergic agonists, resulted in disabling dyskinesias. At the age of 67 years, he underwent a left pallidotomy. On the days following surgery he experienced hallucinations of a school of fish swimming around him. These eventually disappeared. The dose of levodopa was then increased gradually. Four months later he was admitted with disabling dyskinesias and the dose of levodopa was reduced. Three weeks later, whilst watching television, he became unresponsive. His wife noted his eyes were closed and he appeared not to be able to open them. When he opened his eyes, the furniture appeared to be skewed and for 30 min there seemed to be numerous cats in the room with them. They were black or brown and moved silently around the room. One jumped onto his knee and he was able to stroke it; he later recalled the sensation of its fur. The same hallucination recurred almost daily, at any time of day, but it was most common in the early morning or evening. During subsequent similar episodes, his wife noted that he appeared to be petting something at his feet. This hallucination was associated with reduced awareness and responsiveness, but not unconsciousness, and usually lasted 1-3 h. On another occasion the Pope appeared with him whilst travelling in the car and talked to him for up to 2 h.
At the time of interview, between hallucinations, he understood they were not real, but when they were present, his behaviour suggested he did not have full insight. He noted that his sleep was disturbed by vivid dreams and often, on waking, he would appear to be unresponsive with his eyes closed for 30 min. He would have no recall of this time and would not be able to repeat what had been said to him. It did not appear to be a motor 'off' phenomenon, since he was not always rigid and it did not respond to levodopa. The hallucinations often occurred during these episodes, but could also occur at other times too. Between episodes, he showed evidence of mild to moderate cognitive impairment. Investigation with EEG showed no significant abnormality, but we were unable to record during hallucinations or his unresponsive state with ambulatory EEG. His MRI scan showed only the pallidotomy lesion. Cautious reduction of levodopa produced an amelioration of the hallucinations and a slight reduction in the associated unresponsiveness.
Comment. Ball (1882) was the first to suggest that psychiatric disturbance could be part of the clinical picture of Parkinson's disease. Hallucinations were not reported until specific treatments were tried, first anticholinergic agents (Porteous and Ross, 1956) , then levodopa and dopaminergic agonists (Celesia and Barr, 1970; Damasio et al., 1971; Sacks et al., 1972; Sweet et al., 1976; Rondot et al., 1984; Horowski, 1986) . Our case illustrates the severe problems experienced by some patients with Parkinson's disease who receive levodopa. The hallucinations typically start after~10 years of medication, are influenced directly by the dose of therapy and are remarkably similar to those of peduncular hallucinosis. They typically occur at the end of the day and insight is usually preserved. They are associated with sleep disturbances, vivid dreams and episodes of altered arousal (Sanchez-Ramos et al., 1996) . Dopaminergic agonists are much less likely to cause hallucinations when used for other indications, such as hyperprolactinaemia (Turner et al., 1984) . This may, in part, be because Parkinson's disease patients tend to be older, but also because the pattern of pathophysiology in Parkinson's disease predisposes to the hallucinatory effects of these drugs.
This begs the questions: (i) in what way do the pathological changes of Parkinson's disease resemble those of peduncular hallucinosis; and (ii) does levodopa alter the neurochemical changes of Parkinson's disease to mimic those in peduncular hallucinosis (see next section)? The pathology of Parkinson's disease is now recognized to extend beyond the nigrostriatal system (Jellinger, 1990) , with widespread brainstem changes, affecting various neurotransmitter systems and overlapping with peduncular hallucinosis. There is substantial loss of the noradrenergic neurons of the locus coeruleus and serotonergic neurons of the raphe nuclei, especially in the dorsal raphe and the cholinergic parabrachial and pedunculopontine nuclei of the brainstem tegmentum (Halliday et al., 1990; Jellinger, 1990; Duyckaerts et al., 1993) . In Parkinson's disease, subtle deficits of visual pathways have also been described, and are attributed to dopamine deficiency in the retina and perhaps also in central pathways. Addition of levodopa corrects these abnormalities, probably improving the function of the visual system (Bodis-Wollner, 1990); a direct toxic effect of levodopa on vision, therefore, seems most unlikely as a cause of hallucinations.
In more recent years, a group of patients with Lewy body dementia has been identified. These patients appear to have the pathological hallmark of Parkinson's disease with greater cortical involvement. A distinctive clinical characteristic of this disease is the high incidence of complex visual hallucinations, even without levodopa treatment (Gibb, 1989; Kosaka, 1993) . Even patients with Alzheimer's disease who hallucinate, are more likely to have cortical Lewy bodies than those who do not suffer hallucinations (McShane et al., 1995) . As well as extensive cortical abnormalities, patients with Lewy body dementia have more severe pathological changes in the brainstem than those with uncomplicated Parkinson's disease.
Hallucinations associated with migraine and migraine coma
Case 4 (reported previously in Andermann, 1987) This 22-year-old girl had a history of severe occipital, migrainous headaches since childhood, with an aura of flashing white spots. At the age of 15 years, she developed seizures associated with vivid visual hallucinations of a stranger. This person wore white flowing robes and told her she was bad. The attacks responded to carbamazepine. At the age of 21 years she developed prolonged visual and auditory hallucinations, usually when she was reading or sitting quietly. She saw a crowd of Ͼ100 people, some dressed in white. They talked rapidly and she could not understand what they were saying, but they were not threatening. The hallucinations lasted many minutes and were not associated with any headache or motor seizure activity. They disappeared when she put on some music or changed her activity. Her EEGs showed bilateral-occipital and multiple spike and slow-wave bursts increasing on hyperventilation and sensitive to photic stimulation. The discharges tended to block with eye opening.
Comment. This case illustrates prolonged visual hallucinations, resembling peduncular hallucinosis, arising in a patient manifesting the common association between occipital epilepsy and migraine. Although there was no electrographic recording during the ictus in this case, even EEG may be misleading in these cases, with epileptiform abnormalities occurring during migraine aura (Beaumanoir and Jekiel, 1987) . These prolonged hallucinations were unlike the fragmentary visual hallucinations associated with epilepsy (see below and Gloor, 1990) . The overall clinical impression was that they were more likely to be related to her migraine than her epilepsy.
Case 5, migraine coma
A woman (seen at the age of 53 years) had suffered hemiplegic migraine since her teens, in association with mild cerebellar dysfunction, a syndrome described previously (Codina et al., 1971; Zifkin et al., 1980) . For the previous 5 years they had been well controlled with pizotifen. For 3 weeks prior to admission she complained of intermittent right-sided headaches, lasting up to 2 days. These were associated with numbness, usually on the left side of her face. During admission she became somnolent and confused with high fever and hemiparesis, for 48 h. On recovery, she described small, silent, white dogs running around her room. They resolved over 2 days. Once she realized they were hallucinations, she was perplexed by them, but not unduly distressed. A CT scan was normal. Her EEG, during admission, showed a severe generalized slow-wave abnormality. PET of the brain showed diffuse reduction of glucose utilization in both hemispheres. As she was recovering after another episode, she described a tree, a horse and people. These were brightly coloured and silent. As in the previous episode, these disappeared over 1 day. Her son suffered hemiplegic migraine with classical visual aura, also in association with mild, persistent cerebellar abnormalities. He too developed complex visual hallucinations during recovery from hemiplegic episodes.
Comment. Migraine is well recognized as a cause of simple visual hallucinations, but complex visual hallucinations are much rarer. They are seen more frequently in migraine coma and in familial hemiplegic migraine. This syndrome is distinctive in its pattern of inheritance, clinical pattern, severity of symptoms and associated cerebellar signs. The complex visual phenomena were at a late stage of the attack, during recovery, rather than as an aura, at the onset of the headache. This may reflect different pathophysiology from commoner migraine syndromes; familial hemiplegic migraine is due to defects of the calcium channel (Ophoff et al., 1996) . There is no clearly defined pathological change in most cases of migraine, but spreading depression of cortical activity, with parallel changes in blood flow, may be important in the generation of the aura (Leao and Morrison, 1945; Lauritzen, 1987; Lance, 1993; Leao and Welch et al., 1993; Cutrer et al., 1998) .
Visual hallucinations in schizophrenia
Visual hallucinations are probably more common in schizophrenia than traditionally thought (Goodwin et al., 1971; Bracha et al., 1989; Mueser et al., 1990; American Psychiatric Association,1994) . Animals and figures may be prominent, but a delusional or hyper-religious character is often present, that is not usually seen in organic causes (Small et al., 1966) . Schizophrenic hallucinations are also usually in colour (Goodwin et al., 1971) and may be Lilliputian (Lewis, 1961) , and in these cases the hallucinated figures may be felt to be inside the subject's internal organs.
As the illness progresses, the clarity of the hallucination may deteriorate (Lewis, 1961) .
It is difficult to find criteria that clearly differentiate the clinical characteristics of schizophrenic hallucinations from organic causes and hallucinations of manic depression may be even more akin to those of organic disease (Lowe, 1973) . In organic disease, visual hallucinations often occur without auditory hallucinations. Schizophrenics rarely suffer visual hallucinations alone, though they may accompany commoner auditory hallucinations, especially in acute disease and in certain cultures (Frieske and Wilson, 1966; Goodwin et al., 1971; McCabe et al., 1972; Zarroug, 1975; Ndetei and Singh, 1983) . Other associated clinical characteristics may be the most useful in differentiating schizophrenic from organic visual hallucinations. In organic disease they are more often nocturnal and are associated with drowsiness, whereas in schizophrenia they are often present throughout waking hours and are associated with hyper-arousal. In organic cases there is usually more insight, with less paranoia and thought disorder, and the hallucinations carry less 'personal significance' than in schizophrenia (Frieske and Wilson, 1966) .
Hallucinations associated with visual loss
Charles Bonnet syndrome is characterized by complex visual hallucinations occurring in the context of ocular pathology causing visual deterioration, most commonly macular degeneration. In the largest study of the condition to date (Teunisse et al., 1996) , hallucinations occurred in 10% of patients with severe visual loss, generally in the elderly. These hallucinations are rarely stereotyped and they have many of the features of hypnagogic hallucinations, i.e. vivid images of animals and figures and can last for hours (Lalla and Primeau, 1993) . They generally occur with the eyes open and usually in the evening or at night but do not appear to be just illusions triggered by low lighting levels. Most patients have full insight and are not generally distressed by them. Many can stop their hallucination by such manoeuvres as closing or opening their eyes, fixing vision on or away from the hallucination, suggesting it does not have a simple relationship to visual input (Teunisse et al., 1996) . Others have found that hallucinations fall into two categories; brief ones that occur when the patient is alert and longer ones, more like peduncular hallucinosis that occur when the patient is drowsy (Schultz et al., 1996) .
The disturbed visual input may cause hallucinations by an abnormal release of central processing (Taylor et al., 1932; Cogan, 1973) . The level at which the release occurs is not clear. It may not simply be due to withdrawal of physiological input, since secondary chemical and structural changes have been observed in the lateral geniculate nucleus of patients with optic nerve lesions or chronic glaucoma (Chaturvedi et al., 1993; Rango et al., 1995) . Although visual loss is more common in the elderly, the significant predominance of elderly patients (Schultz and Melzack, 1991) raises the possibility that the hallucinations are more likely to occur in individuals with macular disease, if they are superimposed on age-related degenerative CNS changes.
Hallucinations have also been described from lesions of the optic chiasm, radiation and, more commonly, the occipital cortex (Cogan, 1973; Lance, 1976; Serra Catafau et al., 1992; Kolmel, 1993; Vaphiades et al., 1996) Hallucinations from posterior cerebral artery infarction Case 6
A 55-year-old female psychiatric nurse presented with leftsided weakness of acute onset, associated with a feeling of running water down her left side. This had been preceded by 3 days of headache. She was noted to have a left hemianopia and a mild left hemiparesis. The day after admission she developed twitching of her left side associated with drowsiness. The movements settled with phenytoin and benzodiazepines, but the patient remained a little drowsy. During this phase, she described hallucinations affecting her left visual field. She described enormous snakes in vivid colours; she thought they were anacondas, thrashing about in a pool of water. These were seen intermittently over 1-2 days, lasting for hours at a time. At first she was distressed by them, but she soon realized they were not real and remained less affected. An MRI scan showed infarction throughout the territory of the left posterior cerebral artery territory, including occipital cortex and posterior thalamus. Over subsequent weeks the visual field defect contracted.
Case 7
A 54-year-old company director presented with excruciating headache waking him at night. There was a past history of migraine with visual aura, but the current headache was more severe and was not associated with nausea. Seven years earlier he had suffered a road traffic accident with multiple fractures to his left arm and leg, and loss of function in his left arm. On the current admission, he was drowsy with a left homonymous hemianopia and mild left sensory inattention. He was hypertensive (230/110) and funduscopy revealed arteriovenous nipping. A CT scan showed left posterior cerebral artery territory infarction. Over the next few days he experienced visual hallucinations in his left hemifield, lasting hours at a time, consisting of hedgehogs and small brown rodents crawling over the ceiling above him. These recurred particularly when he was drowsy and, although they distressed his wife, he found them curious and amusing. They continued intermittently for 2 weeks, up to the time of writing.
Comment. In these two patients, both occipital cortex and visual thalamus suffered infarction. In other cases the hallucinations may be due to pure occipital infarction.
Typically, the hallucinations are restricted to the abnormal visual field. Ischaemia usually underlies the cortical lesions and there is usually a delay of days to weeks between the ischaemic event and the onset of hallucinations. The hallucinations are usually transient, lasting days or weeks, but they may be more persistent and are restricted to the visual modality unless non-visual cortex is also involved (Vaphiades et al., 1996) . The lesions causing this phenomenon are significantly smaller than those that cause a hemianopia, without any hallucinations (Vaphiades et al., 1996) . This suggests that some intact cortex with visual processing capacity is required to express hallucinations, supporting the concept of a release phenomenon. In most cases there is no disorder of arousal or dreams. In more anterior lesions, affecting the occipito-temporo-parietal cortex, dreams and daytime imagery may be lost (Solms, 1997b) , suggesting a possible double dissociation.
Complex visual hallucinations in focal epilepsy
Epileptic visual hallucinations are generally very different from those of the prolonged hallucinatory states described above. They are usually brief, stereotyped and fragmentary and may be associated with other seizure manifestations, such as experiential phenomena, altered awareness, motor activity and automatisms. Figures are unlikely to be identified, and may appear in colour or black and white. Complex visual hallucinations, more similar to hypnagogic hallucinations, have also been described, but they are rare. They may be prolonged as a form of non-convulsive status epilepticus, and if occurring during sleep may be interpreted as dreams (Sowa and Pituck, 1989; Walker et al., 1995; Solms, 1997a) . If the images are restricted to one visual field, they have lateralizing value for the underlying visual disturbance. They appear to have similar localization and pathophysiological significance to other epileptic visual hallucinations.
Strong evidence, including intracranial EEG recordings and direct cortical stimulation experiments shows that pathological excitation of visual cortical areas is responsible for epileptic, complex visual hallucinations, especially that involving posterior parietal or temporal association cortex (Taylor et al., 1931; Penfield and Jasper, 1954; Ritchie Russell and Whitty, 1955; Penfield and Perot, 1963; Salanova et al., 1992; Williamson et al., 1992) . A key feature of epileptic hallucinations is, therefore, that the visual association cortex is both necessary and sufficient for this phenomenon. This is supported by focal cortical resections resulting in complete remission (Penfield and Jasper, 1954; Penfield and Perot, 1963; Williamson et al., 1992) .
Neuropharmacology of complex visual hallucinations
Drug-induced hallucinations Alcohol, barbiturate and benzodiazepine withdrawal
Acute alcohol withdrawal is a well-recognized cause of visual hallucinations, which are more common in chronic alcoholics but may occur in occasional 'spree' drinkers (Victor and Adams, 1952) . Delirium tremens has been induced experimentally in individuals unaccustomed to habitual alcohol consumption (Isbell et al., 1955) . This suggests that delirium tremens occurs without fixed pathology and is entirely due to metabolic derangement. It usually starts during the period of declining blood ethanol levels, or shortly thereafter. The first symptom is typically tremor, followed by intermittent, brief visual hallucinations, initially without alteration of consciousness. These may lead to profuse, almost continuous visual hallucination, occasionally associated with hallucinations in other modalities. The hallucinations are typically of animals of normal size (celebrated pink elephants), although Lilliputian hallucinations may also occur. Patients often accept them as real at this stage, but find them non-threatening (Fasullo and Lupo, 1973; Lipowski, 1980) . In the earlier stages there are arousal, insomnia and nightmares, which may evolve into continuous, sleepless agitation, the patient talking to imagined people and plucking at imagined objects. Autonomic disturbance is common, especially tachycardia and pyrexia. Generalized convulsions occur in a small proportion of cases, and the hallucinated and agitated state may last several days.
Barbiturates and benzodiazepines cause a chronic dependence state, and sudden cessation is associated with many features in common with alcohol withdrawal: tremor, insomnia, anxiety, autonomic hyperactivity, visual hallucinations and seizures (Isbell et al., 1950; MacKinnon and Parker, 1982) . Both groups of drugs prevent the development of alcoholic delirium tremens and are recommended treatments (Hemmingsen et al., 1979) . Both also act at the GABA receptor site, although by different mechanisms. This close relationship suggests that alcohol withdrawal is related to deficient CNS inhibition, although alterations in monoamines may be important in the agitation, sleeplessness and autonomic changes (Kraus et al., 1985; Baumgartner and Rowen, 1987; Nevo and Hamon, 1995) .
Hallucinogenic drugs
There is a linear correlation between serotonergic activity of hallucinogens and their hallucinogenic potential (Glennon et al., 1984) . The prototypic hallucinogens mescaline and lysergic acid diethylamine tartrate (LSD) cause hypnagogictype hallucinations and are agonists at 5-hydroxytryptamine (5HT 2 ) receptors, despite differing chemical structures. Hallucinations may start with coloured patterns, visual distortions and geometric shapes with features suggesting visual illusions, and progress to include figures of animals and people, sometimes with size distortions and a feeling of fantasy with heightened sensory arousal (Bliss and Clark, 1963; Young, 1974) . Mitchell (1896) described his own mescaline induced hallucinations as more vivid than real life and occurring mainly when relaxed and supine with eyes closed. He was observer rather than participant in the visions and they did not cause particular emotional reactions. Insight is usually preserved and thought disorder or psychosis are not major features (Malitz et al., 1963; Rosenthal, 1964; Aggernaes, 1972) . The hallucinations also lack the symbolism of those in schizophrenia, not being incorporated into a framework of delusional thinking (Hollister, 1962) . LSDinduced visual hallucinations most commonly occur without auditory hallucinations (Bliss and Clark, 1963) , again contrasting sharply with psychoses and resembling peduncular hallucinosis. LSD is particularly active on the serotonergic neurons of the median raphe, which are usually involved in the pathology of peduncular hallucinosis, and on postsynaptic 5HT 2 receptors distributed in the middle layers of the cerebral cortex. Antagonists with action on serotonergic systems may block these effects.
The hallucinations due to amphetamine and cocaine more commonly include auditory hallucinations and more closely resemble schizophrenia with paranoia (Johnson and Milner, 1966; Angrist et al., 1974) . There are differences, however, with less thought disorder and more frequent agitation than in schizophrenia, although blunted emotion is also well recognized (Griffith, 1977) . Cocaine acts at 5HT 3 receptors, which tend to be concentrated in the limbic system, and also at dopamine and catecholamine receptors (Lewander, 1977) . There is no cross-tolerance of its effects with LSD, supporting a different mechanism of action (Jacobs and Azmitia, 1992) .
Pharmacology of hallucinations in Parkinson's disease and Lewy body dementia
Early studies suggested that a confusional state frequently accompanied levodopa-induced hallucinations in Parkinson's disease, but doses of medication used in these studies were high, sometimes 4-5 g/day (Sacks et al., 1972; Sweet et al., 1976; Rondot et al., 1984) . With lower doses, the patient was more likely to hallucinate in clear consciousness, and a reduction in the dose of levodopa could often eliminate confusion and hallucinations. One study found that methysergide (a 5HT 1 and 5HT 2 antagonist) was helpful in preventing hallucinations (Nausieda et al., 1983) . More recently it has been found that the hallucinations can be treated effectively with the atypical neuroleptic, clozapine (dopamine D 4 and 5HT 2 antagonist), risperidone (5HT 2 and D 2 antagonist) and ondansetron (selective 5HT 3 antagonist) (Kahn et al., 1991; Kuiper et al., 1994; Meco et al., 1994) .
There is also evidence of significant cholinergic dysfunction in patients with Parkinson's disease who hallucinate. They are more likely to be older and to have cognitive impairment, than those who do not hallucinate (Sacks et al., 1972; Meco et al., 1990) . They are especially sensitive to anticholinergic agents; they may suffer adverse cognitive effects at doses that do not affect age-matched control subjects (de Smet et al., 1982; Dubois et al., 1987 Dubois et al., , 1990 . In those with cognitive decline there is loss of cholinergic neurons from the basal nucleus of Meynert (which provides diffuse cortical cholinergic input), similar in scale, but different in nature, to that seen in Alzheimer's disease. Whether this can entirely explain their dementia remains unclear; some authors also emphasize the importance of brainstem changes (Gibb, 1989; Jellinger, 1990; Xuereb et al., 1990; Hughes et al., 1993; Kosaka, 1993) . This is pertinent in relation to peduncular hallucinosis in which very similar hallucinations are due to a primary pathology in the brainstem. The basal forebrain nuclei also send excitatory cholinergic projections to the brainstem cholinergic system and thalamic reticular nucleus (Parent et al., 1988) ; there may be an indirect modulation of the function of the reticular formation, which is also disturbed by pathology in the basal forebrain.
Others have also demonstrated a particularly marked reduction in choline acetyl transferase in the cerebral cortices of patients with Lewy body dementia and visual hallucinations. This may be seen as a significantly higher ratio of serotonin to acetylcholine than in control subjects Cheng et al., 1991) . The greatest changes were seen in temporal and parietal cortex, likely sites for expression of complex visual hallucinations. This is an attractive hypothesis, since (i) anticholinergic agents would reduce cholinergic effects still further, so explaining their hallucinogenicity, and (ii) serotonergic antagonists would help correct the imbalance, so explaining their therapeutic effect. A selective serotonin re-uptake inhibitor has also been reported to cause hallucinosis in Parkinson's disease (Lauterbach, 1993) , conforming to this model. But levodopa increases rather than decreases cortical acetylcholine levels and reduces cortical serotonin levels (Mantovani and Pepeu, 1978; Schmidt et al., 1991) . It seems unlikely that levodopa causes hallucinations by a simple perturbation of the serotonin : acetylcholine ratios as in this model, although it increases in the 5-hydroxyindoleacetic acid to 5HT ratio, suggesting there may be some increase in turnover of 5HT (Nausieda et al., 1983; Perry et al., 1993) .
The relationship between cholinergic and serotonergic systems was reviewed recently (Steckler and Sahgal, 1995) . The actions of 5HT on the cerebral cortex are most commonly inhibitory, whereas acetylcholine is generally excitatory (Foote and Morrison, 1987) . The interactions are made more complex by the multiplicity of serotonin receptors. They may be both presynaptic and postsynaptic and there are reciprocal connections between serotonergic and cholinergic systems, especially between the raphe nuclei and the pedunculopontine tegmental nucleus, which are often affected in peduncular hallucinosis (Jellinger, 1990) (Fig. 2) . There are extensive short loop pathways in the brainstem whereby serotonergic neurons modulate the activity of other serotonergic cells (Bliss and Clark, 1963) . A key feature is that the effect of experimental manipulations on the action of serotonergic systems in the brain depends on whether the serotonergic pathways are intact or damaged. In intact animals, exogenous serotonin decreases activity at postsynaptic 5HT 3 receptors by acting primarily on presynaptic 5HT 1A receptors. But if serotonergic neurons are lost, as in peduncular hallucinosis or advanced Parkinson's disease, the predominant effect on presynaptic inhibitory autoreceptors means the action of serotonin at postsynaptic 5HT 3 receptors may be paradoxically increased, despite a reduction in total serotonin content. This could be exacerbated by increased turnover due to levodopa, explaining the apparent discrepancy of reduced serotonin levels in levodopa-treated Parkinson's disease and efficacy of serotonin antagonists in treatment. In addition, in vivo, increase in action of acetylcholine is mediated by presynaptic serotonergic autoreceptors, and if serotonergic neurons are lost, the predominant effect is a reduction of acetylcholine levels, which may predispose to hallucinosis.
Hallucinations are relatively less common in Alzheimer's disease than Lewy body dementia. Although the cholinergic system is particularly affected in Alzheimer's disease, the cholinergic neurons of the pedunculopontine tegmental nucleus are spared and serotonergic neurons are also less affected than in Lewy body disease (Jellinger, 1990) .
Drug treatment of other causes of visual hallucinations
Hypnagogic hallucinations of narcolepsy are best treated by monoamine oxidase inhibitors that have a powerful serotonergic effect and block rapid eye movement (REM) sleep, or by clomipramine or protriptyline, which delay onset of the first REM period and also influence 5HT 2 receptors (Wyatt et al., 1971; Schmidt et al., 1977; Hishikawa and Shimizu, 1995) .
Much of the neurobiology of schizophrenia remains elusive (Chan, 1985; Carpenter and Buchanan, 1994; Chua and McKenna, 1995; Gold and Weinberger, 1995) . The potency of drugs in the treatment of schizophrenia correlates very closely to dopamine D 2 antagonist activity, but abnormalities of the dopamine system are difficult to identify in the disease (Mackay and Iversen, 1992) . Clozapine is an antipsychotic agent said to be especially effective against hallucinations and in schizophrenia refractory to dopaminergic agents. It has strong antiserotonergic activity, especially at 5HT 2 receptor subtypes, as well as dopamine D 4 antagonist activity. Clozapine resistance is associated with changes in the 5HT 2 receptor, suggesting this is a critical site of action (Williams et al., 1997) , and serotonin-dopamine interactions may be crucial in schizophrenia (for review, see Roth and Meltzer, 1995) .
Migraine aura is blocked by pizotifen and methysergide (5HT 2 antagonists), but not by sumatriptan (5HT 1 agonist) which treats the headache. Brainstem aminergic structures, including the noradrenergic locus coeruleus and serotonergic dorsal raphe nucleus, may also affect cerebral blood flow (Lance, 1993) , influencing spreading depression in migraine aura.
These many lines of evidence converge to support the importance of serotonergic mechanisms in visual hallucinations, most likely at 5HT 2 receptors, but these are influenced by the pattern of pathology, the activity of other neurotransmitter systems and the interactions of serotonergic presynaptic and postsynaptic receptors.
Sleep mechanisms and disturbances in visual hallucinosis
Sleep disturbances are common in patients with vivid formed hallucinations (Table 1) . Many reports of peduncular hallucinosis describe altered sleep and states of inaccessibility, but it is generally unclear to what extent they coincide with hallucinations (Lhermitte, 1922; Lhermitte and Levy, 1931; van Bogaert, 1924; Dunn et al., 1983; Geller and Bellur, 1987; Feinberg and Rapcsak, 1989; Kolmel, 1991; Tsukamoto et al., 1993; Nadvi and van Dellen, 1994) . One recent report (Bassetti et al., 1996) described two patients with symptoms suggestive of peduncular hallucinosis in the context of paramedian thalamic infarction. Both patients suffered hypersomnia with a marked increase in Stage 1 non-rapid eye movement (non-REM) sleep, a slight reduction in Stage 2 and marked reductions in Stage 3-4 sleep. There was relatively little change in REM sleep.
Sleep disturbances have been best characterized in narcolepsy-cataplexy syndrome. The cardinal symptoms of this condition (excess daytime sleepiness, sleep paralysis, cataplexy and hypnagogic hallucinations) seem to represent a breakdown in the co-ordination of the fundamental components of REM sleep: dreaming, atonia and sleep itself, with their intrusion into the waking state. Whereas normal individuals usually do not experience their first REM sleep period within the 90 min after sleep onset, patients with narcolepsy frequently enter REM sleep within 20 min of sleep onset. Hallucinations are related to this first REM, especially if its onset is rapid (Hishikawa et al., 1978) , and not to later REM episodes or total REM time, which is normal in narcolepsy (Hishikawa and Shimizu, 1995) . In normal individuals, the first REM epoch arises out of deep non-REM sleep. Hallucinations may be a manifestation of going into REM from a relatively higher level of arousal (Hishikawa et al., 1968) . This would explain why these hallucinations only occur in the first REM epoch.
Most cases of the narcolepsy syndrome are constitutional but some are secondary to lesions of the pons and midbrain (Stahl et al., 1980; Rivera et al., 1986; Aldrich and Naylor, 1989; Autret et al., 1994; D'Cruz et al., 1994; Plazzi et al., 1996) , overlapping considerably with those causing peduncular hallucinosis. It seems likely that in these two situations, hallucinations share a similar pathophysiological basis. In idiopathic narcolepsy there is evidence of altered brainstem function. Increased brainstem blood flow has been shown during sleep, the reverse of that in normal individuals (Sakai et al., 1979) . During hypnagogic hallucinations, an increase has also been shown, especially in right parietal, occipital and posterior temporal cortex (Meyer et al., 1980) .
In most forms of hallucinosis, including Charles Bonnet syndrome, in which there is no direct CNS pathology, hallucinations are most prominent at the end of the day. The patient in our Case 1 experienced hallucinations when drowsy but not at other times, even in darkness. There are patients with no perception of light, whose hallucinations also generally occurred in the evening (R. J. Teunisse, personal communication) . This supports the importance of arousal and brainstem activity, rather than low levels of ambient lighting, in triggering hallucinations, even in patients whose primary pathology resides outside the brainstem. In the absence of visual input, brainstem structures are the major controlling influence on the firing of lateral geniculate neurons in the cat (McCarley et al., 1983) and these are directly affected by alcohol and drugs. Enucleation increases the turnover of serotonin, a key neurotransmitter in hallucinosis, in the dorsal lateral geniculate nucleus (Vizuette et al., 1992) .
It may not merely be a coincidence of anatomy that these two systems controlling arousal and causing hallucinosis are affected together in these disorders. An important component of sleep is the switching of thalamic relay nuclei out of waking relay mode, in which they faithfully transmit sensory inputs to the cortex, into sleeping burst mode, in which they do not. Brainstem connections to the midline thalamic nuclei and to the thalamic reticular nucleus are especially important for this function. Lesion studies have shown that structures within the pontine reticular formation are crucial for the generation of REM sleep, especially the nucleus reticularis pontis oralis (Jones, 1994 ). An abnormality could cause a sleep disturbance and abnormal cortical processing of sensory afferents. One mechanism by which this may occur is alteration of ponto-geniculo-occipital (PGO) waves, a specific pattern of electrical activity generated in animals in association with REM sleep (Hartmann, 1994) . PGO waves appear 30-90 s before REM sleep but their precise role is unclear (Steriade et al., 1989) . PGO-related bursts are probably generated by the cholinergic pedunculopontine nucleus, and they are inhibited by serotonergic raphe nuclei (Ruch-Monachon et al., 1976; Gaillard et al., 1994) . In the dorsal lateral geniculate nucleus, nicotinic and muscarinic cholinergic inputs are important in generating PGO spikes (Steriade et al., 1989; Luebke et al., 1992; Siegel, 1994) , where they may be involved in modulating the phasic discharge of thalamic units (Laurent et al., 1977) . LSD induces hallucinatory behaviour in cats associated with an increase in eye movement potentials, which resemble 'waking PGO waves' (Jacobs et al. 1972) . Barbiturates also suppress these waves and barbiturate withdrawal may lead to increased expression.
Poor sleep, frequent arousals and nightmares are common complaints of patients with Parkinson's disease who are treated with levodopa. Various objective sleep disturbances have been reported in the untreated state, including reduced, unchanged or increased REM sleep and loss of REM atonia (for references, see Mouret, 1975; Myslobodsky et al., 1982; Askenasy and Yahr, 1985) . Since both the REM-generating cholinergic and the REM inhibiting serotonergic brainstem structures are affected by Parkinson's disease, it is possible that the balance of pathology in these structures varies from case to case, producing different effects on sleep. Levodopa and dopaminergic agonists, such as apomorphine appear to increase sleep fragmentation, reduce total sleep time and, especially, reduce REM sleep (Gillin et al., 1973; Aldrich, 1994) . In Parkinson's disease patients with hallucinations, a number of abnormalities have been seen when compared with control Parkinson's disease patients without hallucinations, matched for age, disease duration, motor function and treatment. These include reduced total sleep time and efficiency. There was a marked reduction in REM sleep (5 versus 20%) and an increase in motor activity during REM sleep, consistent with REM behaviour disorder (Comella et al., 1993) . These effects presumably reflect the increased pathology in brainstem structures controlling sleep, especially those generating REM sleep, and associated atonia, resulting in increased sensitivity to the effects of levodopa.
Hyper-arousal with reduced sleep is usually seen with drug-induced hallucinations, alcohol withdrawal and schizophrenia. The EEG in delirium tremens may show a curious pattern with rapid eye movements during Stage 1 sleep (Kaneko and Hishikawa, 1981) . This may reflect a breakdown of the co-ordination of the components of REM sleep, analogous to that in the narcolepsy-cataplexy syndrome.
Corticothalamic mechanisms in the generation of complex visual hallucinations
Two neurotransmitters that appear to be particularly important in visual hallucinations, serotonin and acetylcholine, are concentrated in the visual thalamic nuclei and visual cortex rather than in regions involved in other sensory modalities (Morrison and Foote, 1986; Fitzpatrick et al., 1989; Parent, 1996) . Thus the predominance of visual hallucinations over other sensory modalities can be reconciled with potentially important cholinergic-serotonergic interactions in either visual thalamus or visual cortex but does not differentiate between these two sites.
Cortical involvement
Several lines of evidence point to a release of inhibition of association cortex being central to many forms of complex visual hallucinosis.
(i) There is strong evidence that the complex visual hallucinations of epilepsy are due to pathology affecting visual association cortex. In contrast, nearly all the reported cases of complex visual hallucinations following stroke are due to occipital infarction, rather than commoner middle cerebral artery infarctions, and there appears to be a double dissociation of lesions underlying hallucinations and those causing loss of visual imagery in which association cortex is affected. These differences are consistent with the hypothesis that epilepsy stimulates the visual association cortex directly, whereas hemianopic strokes release it from a distance. One possible pathway of this release is by loss of direct corticocortical inputs (Jones and Powell, 1970 ). An alternative is by loss of the substantial striate cortex control of thalamic inputs to the visual association cortices.
(ii) A key feature of Lewy body dementia that differentiates it from Parkinson's disease (unaccompanied by hallucinations in the absence of treatment) is the extent of cortical involvement with cholinergic and serotonergic changes, especially in the association cortex (Perry et al., 1991; Kosaka, 1993) .
(iii) 5HT 2 receptors (the main target of LSD and mescaline) are especially concentrated in the cerebral cortex (Steckler and Sahgal, 1995) . Serotonergic neurons vary their activity in relation to the state of arousal. They have intrinsic rhythmicity and generally discharge slowly. Many neurons do not make specific postsynaptic contacts. These characteristics suggest that serotonergic neurons are unlikely to be important in the transfer of specific sensory information in visual hallucinations. They are much more likely to have a modulatory effect on the activity of sensory pathways and cortical responses (Jacobs and Azmitia, 1992) , perhaps explaining the interaction of visual pathway and brainstem disturbances in the generation of visual hallucinations.
Thalamic involvement
Both the dorsal lateral geniculate nucleus and lateral pulvinar are under brainstem control and act as a junction for the brainstem modulation of inputs to visual cortex. In support of this is the close relationship between hallucinations and alterations in sleep and arousal, which is another 'gating' function in which the same nuclei and transmitter systems are critical.
The dorsal lateral geniculate nucleus is the best understood thalamic visual area. A major electrophysiological effect of reticular formation stimulation on dorsal lateral geniculate nucleus cells is release from inhibition and release from the control of retinal afferents (reviewed in Singer, 1977) . The extensive cholinergic and serotonergic inputs from the brainstem to the dorsal lateral geniculate nucleus are both direct and indirect (via the reticular nucleus of the thalamus) (Fig. 3) . The cholinergic input, from the parabrachial nucleus and the parabigeminal nucleus, is excitatory both directly to dorsal lateral geniculate nucleus and also by inhibiting the GABAergic inhibitory input from the reticular nucleus of the thalamus (Pasik et al., 1990; Wilson, 1993) . The serotonergic input, from the dorsal raphe, inhibits cholinergic excitation, probably via 5HT 1 and 5HT 3 receptors and also suppresses responses to retinal inputs (Rogawski and Aghajanian, 1980; Kemp et al., 1982) . Therefore, the raphe lesion of peduncular hallucinosis may cause excitation of the dorsal lateral geniculate nucleus, at the same time reducing the fidelity of retinogeniculate transmission. This is an ideal combination for the generation of hallucinations. The same pathways are involved in the control of sleep and the fidelity of geniculostriate transmission also depends on sleep-stage. The level of arousal may, therefore, be particularly important in determining the occurrence of these hallucinations, and a sleep disturbance would be a common accompaniment.
A recent study suggested that a variety of (non-visual) positive symptoms may be related to pathological burst patterns of neurons in the thalamus, produced by calcium spikes when thalamic cells are in the hyperpolarized state (Jeanmonod et al., 1996) . Many of the lesions causing hallucinations could act on this mechanism by increasing inhibition in the thalamus. Corticothalamic, retinothalamic and cholinergic brainstem inputs are all excitatory to the thalamus, and lesions of any of these may predispose to the production of calcium spikes. As discussed above, serotonin reduces cholinergic excitation in the thalamus, and hallucinogens may also increase thalamic inhibition. Similarly, in Parkinson's disease, as well as effects on brainstem nuclei, there is an increase in tonic inhibition of the thalamus from the pallidum, but whether this extends to visual thalamus is not clear. Slow-wave sleep is also thought to be manifest by low threshold calcium spikes, providing a mechanism for predisposing to these pathological effects at times of drowsiness (Tsoukatos et al., 1997) .
In an analogous situation, phantom limb hallucinations may occur in those with congenitally absent limbs, suggesting that the phenomenon may occur with release from the primary sensory pathway (Melzack et al., 1997) . Recent stimulation studies show that the thalamic representation of the limb remains functional after amputation (Davis et al., 1998) .
Although the dorsal lateral geniculate nucleus is the major projection nucleus to the striate cortex, the pulvinar lateral posterior complex is also important in visual processing, having reciprocal connections with extrastriate visual areas. Even with complete striate lesions, the response characteristics of neurons in the middle temporal gyrus to visual stimuli is relatively unchanged (Girard et al., 1992) . A much greater change is seen if there is a simultaneous superior colliculus lesion. The superior colliculus influences this cortical region via the pulvinar complex this centre may be important in extrastriate visual function. The microscopic anatomy and chemoarchitecture of the pulvinar appear to be similar to the better studied dorsal lateral geniculate nucleus (Mathers, 1972; Hajdu et al., 1974; Ogren and Hendrickson, 1979; Cusick et al., 1993) . The pulvinar receives direct retinal input (Cowey and Stoerig, 1991) , also particularly dense cholinergic afferents, including those from the pedunculopontine tegmental nucleus, and serotonergic inputs from the brainstem raphe (Rodrigo-Angulo and ReinosoSuarez, 1982; Morrison and Foote, 1986; Parent et al., 1988; Fitzpatrick et al., 1989) . A function of the pulvinar may be to filter out irrelevant information, especially in relation to eye movements (Robinson and Petersen, 1992) . A corruption of this function of serotonin in the thalamus might increase 'signal-to-noise ratio' in visual transmission and contribute to visual illusions or hallucinations.
Complex visual phenomena from simple lesions
Striking features of these visual images are their complexity, sophistication and similarity across different lesion sites and pathologies. An analogy may be seen in the experiential attacks of some patients with temporal lobe epilepsy, in which there is a complex interplay of hallucinatory experience, a strong affective component (usually fear) and a component of memory recall (Taylor et al., 1931; Penfield and Perot, 1963; Halgren et al., 1978; Gloor et al., 1982; Bancaud et al., 1994) . Gloor used the example of temporal lobe epilepsy to provide an hypothesis to explain how non-physiological, epileptic activation of part of a functional neuronal network can result in an almost intact mental experience (Gloor, 1990) . This concept of a distributed network is supported by experimental data, in which similar responses were elicited by stimulation of frontal and temporal lobes (Fish et al., 1993) . The hypothesis finds its roots in Hughlings Jackson's 'dissolution of the CNS' (Taylor et al., 1932) . It may explain how different pathologies may produce similar cognitive effects by interfering with a neuronal matrix at different sites and how complex mental phenomena, such as formed visual hallucinations, may arise as a result of fairly blunt pathological insults, probably via a release of association cortex (Gloor, 1990) . For example, brainstem pathology, outside the primary visual system, may act on thalamocortical relationships to generate vivid and complex visual hallucinations similar to those seen with direct lesions of afferent visual pathways.
Summary
Normal individuals may experience prolonged hypnagogic hallucinations prior to falling asleep. These are characterized by brilliant scenery, figures and animals, and insight is often preserved. Strikingly similar hallucinations are seen in lesions of the visual pathways, and in brainstem and thalamic lesions affecting the ascending reticular activating system. Evidence from chemical hallucinogens points to the importance of serotonin, probably acting via 5HT 2 receptors. Brainstem lesions associated with hallucinations tend to affect the ascending reticular activating system, including serotonergic pathways, and are often associated with a sleep disturbance. They include peduncular hallucinosis and secondary narcolepsy-cataplexy syndrome. Even in conditions in which hallucinations are not associated with sleep disorders, such as Charles Bonnet syndrome and occipital lesions, hallucinations are more likely to occur when the individual is drowsy, suggesting a role for the reticular activating system.
Smaller rather than larger occipital lesions tend to be associated with hallucinations, and more anterior association cortex lesions cause a loss of visual imagery. It appears that the capacity for generating hallucinations is in association cortex and that it is released by restricted lesions but prevented by larger or more anterior lesions.
We postulate that hallucinations in these pathologies share a release of visual association cortex, acting by loss of cortico-cortical inputs, and alteration of activity via effects on the reticular activating system, especially serotonergic inputs. These mechanisms may explain how such strikingly similar hallucinations may be produced by various pathologies at different sites.
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